Cargando…
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
BACKGROUND: In patients with oligometastatic recurrent prostate cancer, standard treatment is androgen deprivation therapy (ADT). However, ADT has many potential side effects that may result in impaired quality of life. Early identification to select patients suitable for stereotactic ablative radio...
Autores principales: | Deijen, Charlotte L., Vrijenhoek, Gerbert L., Schaake, Eva E., Vogel, Wouter V., Moonen, Luc M.F., Pos, Floris J., van der Poel, Henk G., Borst, Gerben R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261473/ https://www.ncbi.nlm.nih.gov/pubmed/34278008 http://dx.doi.org/10.1016/j.ctro.2021.06.004 |
Ejemplares similares
-
68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer
por: Kalinauskaite, Goda, et al.
Publicado: (2020) -
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
por: Pasqualetti, Francesco, et al.
Publicado: (2016) -
The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer
por: Erdoğan, Mehmet, et al.
Publicado: (2020) -
Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020) -
Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
por: Gawish, Ahmed, et al.
Publicado: (2022)